Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11126
CALL
GrowGeneration
GRWG
$104M
| $94.1K | ﹤0.01% |
44,200
-44,300
| -50% | -$95K |
|
11127
CALL
iShares MSCI World ETF
URTH
$8.39B
| $94.1K | ﹤0.01% |
+600
| New | +$90.4K |
|
|
GIFI
11128
DELISTED
Gulf Island Fabrication
GIFI
| $94.1K | ﹤0.01% |
16,682
-17,594
| -51% | -$103K |
|
11129
PUT
Akebia Therapeutics
AKBA
$242M
| $94K | ﹤0.01% |
71,200
-6,300
| -8% | -$8.41K |
|
11130
CALL
Columbia Financial
CLBK
$1.23B
| $93.9K | ﹤0.01% |
5,500
-3,300
| -38% | -$55.6K |
|
11131
PUT
BigBear.ai
BBAI
$1.57B
| $93.9K | ﹤0.01% |
64,300
-8,300
| -11% | -$12.3K |
|
|
NREF
11132
CALL
NexPoint Real Estate Finance
NREF
$319M
| $93.8K | ﹤0.01% |
+6,000
| New | +$90.1K |
|
11133
PUT
Trinity Capital Inc
TRIN
$1.72B
| $93.6K | ﹤0.01% |
6,900
-600
| -8% | -$8.48K |
|
|
FM
11134
CALL
DELISTED
iShares Frontier and Select EM ETF
FM
| $93.6K | ﹤0.01% |
+3,400
| New | +$94K |
|
|
SLSR
11135
Solaris Resources
SLSR
$1.29B
| $93.6K | ﹤0.01% |
+35,924
| New | +$87.6K |
|
11136
CALL
Oportun Financial
OPRT
$355M
| $93.6K | ﹤0.01% |
33,300
+23,700
| +247% | +$68.8K |
|
11137
PUT
Invesco DB Base Metals Fund
DBB
$315M
| $93.6K | ﹤0.01% |
4,500
-1,700
| -27% | -$33.1K |
|
|
RCM
11138
PUT
DELISTED
R1 RCM Inc. Common Stock
RCM
| $93.5K | ﹤0.01% |
6,600
-600
| -8% | -$8.15K |
|
11139
Protalix BioTherapeutics
PLX
$179M
| $93.5K | ﹤0.01% |
91,658
+73,190
| +396% | +$77K |
|
|
NVEE
11140
PUT
DELISTED
NV5 Global
NVEE
| $93.5K | ﹤0.01% |
4,000
| – | – |
|
|
SCPH
11141
CALL
DELISTED
scPharmaceuticals
SCPH
| $93.5K | ﹤0.01% |
20,500
-6,800
| -25% | -$32.9K |
|
11142
Cato Corp
CATO
$67.9M
| $93.4K | ﹤0.01% |
18,725
-38,257
| -67% | -$189K |
|
11143
CALL
Gossamer Bio
GOSS
$75.4M
| $93.4K | ﹤0.01% |
94,700
-16,800
| -15% | -$16.2K |
|
11144
PUT
Blend Labs
BLND
$352M
| $93.4K | ﹤0.01% |
24,900
-13,900
| -36% | -$46.1K |
|
11145
PUT
SELLAS Life Sciences
SLS
$2.58B
| $93.4K | ﹤0.01% |
74,700
+63,000
| +538% | +$77K |
|
11146
ProShares Ultra Technology
ROM
$1.32B
| $93.3K | ﹤0.01% |
+1,391
| New | +$90K |
|
|
FOCL
11147
EDAP TMS S.A.
FOCL
$178M
| $93.2K | ﹤0.01% |
36,563
+1,527
| +4% | +$6.25K |
|
11148
CALL
AdvisorShares Pure Cannabis ETF
YOLO
$32.3M
| $93K | ﹤0.01% |
28,500
+9,700
| +52% | +$32.3K |
|
11149
Rockwell Medical
RMTI
$29.2M
| $93K | ﹤0.01% |
2,342
-8,041
| -77% | -$216K |
|
|
OTLY
11150
PUT
Oatly Group
OTLY
$441M
| $93K | ﹤0.01% |
5,440
-1,820
| -25% | -$34.2K |
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.